Fund managers including L1 Capital, Endeavor Asset Management, Blackwattle Investment Partners, Oracle Advisory Group, Equity Trustees Asset Management, Cordis Asset Management, Pengana Capital Group, Totus Capital, Swell Asset Management, Airlie Funds Management, ELM Responsible Investments, ECP Asset Management, Selector Funds Management, Clime Investment Management, Sterling Managed Investments, Alliance Bernstein, SG Hiscock & Company, Alphinity Investment Management, Yarra Capital Management, Pendal Group, Auscap Asset Management, Infinity Asset Management, NAOS Asset Management, Paradice Investment Management, Wilson Asset Management, TMS Capital, Flagship Investments, Perennial Partners, Katana Asset Management, Sage Capital, Investors Mutual Limited, Ten Cap, Quest Asset Partners, ClearBridge Investments, Elston Asset Management, Plato Investment Management, Nanuk Asset Management, Perpetual Asset Management and Alvia Asset Partners have invested in Resmed CDI (ASX:RMD).

Investors Mutual highlights ResMed's dominance of the global CPAP market with more than 15 million cloud-connected patients, 10% earnings growth and forecast EPS growth of around 30% over three years. ClearBridge and Ten Cap see an attractive valuation after the med-tech sell-off, and Pendal views the software divestment as sharpening focus.

Elston notes two key concerns: Philips re-entering the sleep apnoea device market and GLP-1 drugs potentially shrinking the addressable patient population. ClearBridge also cites pressure on healthcare stocks from bond yields and US health insurers denying claims.

ResMed, Inc. is a digital health company specializing in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases. Founded in 1989 and headquartered in San Diego, CA, ResMed operates through two primary segments: Sleep and Respiratory Care and Software as a Service (SaaS). The Sleep and Respiratory Care segment focuses on medical devices for sleep and respiratory disorders. The SaaS segment provides business management software for out-of-hospital healthcare providers. ResMed’s technologies aim to improve patient outcomes through integrated digital health solutions.